Ironwood Pharmaceuticals to acquire Swiss biotech company VectivBio

Ironwood Pharmaceuticals to acquire Swiss biotech company VectivBio

Ironwood Pharmaceuticals, a gastrointestinal (GI)-focused healthcare company, has agreed to acquire VectivBio Holding AG, a Switzerland-based biotech company, listed on the Nasdaq, for around $1 billion, including the latter’s debt. Shareholders of VectivBio will be paid $17 per share in cash. VectivBio is a clinical-stage biopharmaceutical company headquartered in Basel, specializing in the development of […]

Roche acquires Irish inflammasome company Inflazome for €380m

Roche acquires Irish inflammasome company Inflazome for €380m

Roche acquisition of Inflazome : Swiss drug giant Roche has acquired Irish biotech company Inflazome, a developer of inflammasome inhibitors, for an upfront payment of €380 million. The Irish pharma company will also stand to get additional contingent payments, which will be based on the meeting of certain predetermined milestones. Inflazome was a portfolio company […]